67 : 61 : 07 : 12 . Tuberculin screening requirements. A designated staff member shall conduct tuberculin screening for the absence or presence of symptoms with each client newly admitted to outpatient treatment, intensive outpatient, day treatment, clinically-managed , low - intensity residential treatment, clinically - managed detoxification, or intensive inpatient treatment , within twenty-four hours of admission , to determine if the client has had any of the following symptoms within the previous three months:

1. (1) Productive cough for a duration of two-three weeks;
2. (2) Unexplained night sweats;
3. (3) Unexplained fevers; or

4. (4) Unexplained weight loss.

   Any client determined to have had one or more of the listed symptoms within the last three months must be immediately referred to a licensed physician for a medical evaluation to determine the absence or presence of active tuberculosis. A physician, physician assistant, nurse practitioner, or clinical nurse specialist may request that a Mantoux skin test be conducted. Any client confirmed or suspected to have infectious tuberculosis may not be admitted for services until the client is determined to no longer be infectious by the physician. If infectious tuberculosis is ruled out, the evaluating physician must provide a written statement confirming the client does not have tuberculosis before the client may be admitted for services.

   Reference: Guidelines for Preventing the Transmission of Mycobacterium tuberculosis in Health-Care Settings, 2005, December, 2005. "Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report, Recommendations and Reports," December 30, 2005/Vol. 54/No.RR-17. Copies are available free of charge from the following website: https://www.cdc.gov/mmwr/preview/mmwrhtml/rr5417a1.htm.

Source: 43 SDR 80 , effective December 5, 2016; 50 SDR 63, effective November 27, 2023 .

General Authority: SDCL 1-36-25 , 34-20A-27 .

Law Implemented: SDCL 34-20A-27 .

Prior versions effective: 2016-12-05.